2024-05-19
2024-02-08
November 21, 2024
Summary | |
---|---|
Cancer Type | Lung Cancer |
Grade | NA |
Stage | NA |
Ethnicity | Asian |
Gender | F |
Age | 65 |
Pathology Diagnosis | Large cell anaplastic carcinoma |
Biopsy Site | NA |
Treatment History | NA |
Pathology QC | Poorly differentiated squamous cell carcinoma (P13) |
Special Features | Derived from LU1901 by continuous Crizotinib treatment. MET amplified, EGFR amplified |
Mouse Strain | Balb/c nu |
TMA | TMA-HP-LU-022 |
Viral Status in PDX | NA |
Available In | CB_CN |
RNA Seq | P11 |
Exome Seq | P11 |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy